PATENT CLAIM ANALYSIS

Application Number: 15998570
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "560000"]

Abstract:
In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing or preventing HDL oxidation in a subject, the method comprising administering to the subject a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.

Claim (Index 13):
The method of  claim 1 , wherein the cardiovascular disease is an atheromatous cardiovascular disease.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 96.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15415667', '15312113', '14729615', '13735660', '13705990']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6104027400376284
- 35 USC 102 Novelty (BERT): 0.5930206689081011
- Combined Prediction Score: 0.6086645329246757
- Mean Citation Score: 403.257442
- Max Citation Score: 603.77594
- Similarity Product: 374.12188368207336

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test